Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEPS-EA trial of intralesional triamcinolone for esophageal strictures after esophageal atresia repair
NL-OMON60647Phase 4Recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of triamcinolone acetonide in Esophageal stricture and esophageal atresia (EA) (2 arms), sponsored by Erasmus MC. Started Jan 2024; status: recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
Esophageal strictureesophageal atresia (EA)
Beyond the preview
Go deeper on NL-OMON60647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60647.